Quantitative hepatitis B core antibody (qAnti‐HBc) level has been reported to predict significant liver inflammation in treatment‐naïve chronic hepatitis B patients. However, little evidence has been revealed that qAnti‐HBc alone… Click to show full abstract
Quantitative hepatitis B core antibody (qAnti‐HBc) level has been reported to predict significant liver inflammation in treatment‐naïve chronic hepatitis B patients. However, little evidence has been revealed that qAnti‐HBc alone or with other serum parameters in predicting moderate to severe hepatic inflammation in HBeAg‐positive immune active patients treated with entecavir (ETV).
               
Click one of the above tabs to view related content.